Expression of metallothionein mRNAs on mouse cerebellum microglia cells by thimerosal and its metabolites

Toxicology

Volumn 261, Issue 1-2, 2009, Pages 25-32

  Minami, Takeshi ^a   Miyata, Eriko ^a   Sakamoto, Yamato ^a   Kohama, Azusa ^a   Yamazaki, Hideo ^a   Ichida, Seiji ^a  

^a KINKI UNIVERSITY   (Japan)

Author keywords

C8 B4 cell; Ethyl mercury; Metallothionein; NG108 15 cell; Thimerosal; Thiosalicylate

Indexed keywords

ETHYLMERCURIC CHLORIDE; MERCURY; MESSENGER RNA; METALLOTHIONEIN; THIOMERSAL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL LINE; CELL PROLIFERATION; CELL VIABILITY; CEREBELLUM; CONTROL GROUP; CONTROLLED STUDY; DOSE RESPONSE; INCUBATION TIME; METABOLITE; MICROGLIA; MOUSE; NEUROBLASTOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALPHA-FETOPROTEINS; ANIMALS; BIOTRANSFORMATION; CELL LINE; CELL SURVIVAL; CEREBELLUM; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; METALLOTHIONEIN; MICE; MICROGLIA; NERVE TISSUE PROTEINS; PRESERVATIVES, PHARMACEUTICAL; RATS; RNA, MESSENGER; SALICYLIC ACIDS; SULFHYDRYL COMPOUNDS; THIMEROSAL; TIME FACTORS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 66049129453     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2009.04.037     Document Type: Article

References (53)

1. Agullo L., Garcia A., and Hidalgo J. Metallothionein-I + II induction by zinc and copper in primary cultures of rat microglia. Neurochem. Int. 33 (1998) 237-242
2. Bernard S., Enayati A., Redwood L., Roger H., and Binstock T. Autism: a novel form of mercury poisoning. Med. Hypotheses 56 (2001) 462-471
3. Blaauwgeers H.G.T., Sillevis Smitt P.A.E., de Jong J.M.B.V., and Troost D. Distribution of metallothionein in the human central nervous system. Glia 8 (1993) 62-70
4. Carrasco J., Penkowa M., Giralt M., Camats J., Molinero A., Campbell I.L., Palmiter R.D., and Hidalgo J. Role of metallothionein-III following central nervous system damage. Neurobiol. Dis. 13 (2003) 22-36
5. Cherian M.G., Jayasurya A., and Bay B.-H. Metallothioneins in human tumors and potential roles in carcinogenesis. Mutat. Res. 533 (2003) 201-209
6. Clarkson T.W. The three modern faces of mercury. Environ. Health Perspect. 110 Suppl. 1 (2002) 11-23
7. Clements C.J., and McIntyre P.B. When science is not enough - a risk/benefit profile of thiomersal-containing vaccines. Expert. Opin. Drug Saf. 5 (2006) 17-29
8. Coyle P., Philcox J.C., Carey L.C., and Rofe A.M. Metallothionein: The multipurpose protein. Cell. Mol. Life Sci. 59 (2002) 627-647
9. Daniels P.J., and Andrews G.K. Dynamics of the metal-dependent transcription factor complex in vivo at the mouse metallothionein-I promoter. Nucleic Acids Res. 31 (2003) 6710-6721
10. Datta J., Majumder S., Kutay H., Motiwala T., Frankel W., Costa R., Cha H.C., MacDougald O.A., Jacob S.T., and Ghoshal K. Metallothionein expression is suppressed in primary human hepatocellular carcinomas and is mediated through inactivation of CCAAT/enhancer binding protein α by phosphatidylinositol 3-kinase signaling cascade. Cancer Res. 67 (2007) 2736-2746
11. Endo T., Yoshikawa M., Ebara M., Kato K., Sunaga M., Fukukda H., Hayasaka A., Kondo F., Sugiura N., and Saisho H. Immunohistochemical metallothionein expression in hepatocellular carcinoma: relation to tumor progression and chemoresistance to platinum agents. J. Gastroenterol. 39 (2004) 1196-1201
12. Francois G., Duclos P., Margolis H., Lavanchy D., Siegrist C.A., Meheus A., Lambert P.H., Emiroglu N., Badur S., and Van Damme P. Vaccine safety controversies and the future of vaccination programs. Pediatr. Infect. Dis. J. 24 (2005) 953-961
13. Gallagher C., and Goodman M. Hepatitis B triple series vaccine and developmental disability in US children aged 1-9 years. Toxicol. Environ. Chem. 90 (2008) 997-1008
14. Geier D.A., and Geier M.R. A meta-analysis epidemiological assessment of neurodevelopmental disorders following vaccines administered from 1994 through 2000 in the United States. Neuro. Endocrinol. Lett. 27 (2006) 401-413
15. Geier D.A., Sykes L.K., and Geier M.R. A review of thimerosal (merthiolate) and its ethylmercury breakdown product: specific historical considerations regarding safety and effectiveness. J. Toxicol. Environ. Health, Part B 10 (2007) 575-596
16. Ghazi I.E., Martin B.L., and Armitage I.M. Metallothionein-3 is a component of a multiprotein complex in the mouse brain. Exp. Biol. Med. 231 (2006) 1500-1506
17. Ghoshal K., Majumder S., Li Z., Dong X., and Jacob S. Supperssion of metallothionein gene expression in a rat hapatoma because of promoter-specific DNA methylation. J. Biol. Chem. 275 (2000) 539-547
18. Guzzi G., and La Porta C.A.M. Molecular mechanisms triggered by mercury. Toxicology 244 (2008) 1-12
19. Haq F., Mahoney M., and Koropatnick J. Signaling events for metallothionein induction. Mutat. Res. 533 (2003) 211-226
20. Hozumi I., Uchida Y., Watabe K., Sakamoto T., and Inuzuka T. Growth inhibitory factor (GIF) can protect from brain damage due to stab wounds in rat brain. Neurosci. Lett. 395 (2006) 220-223
21. Huang Y., De La Chapelle A., and Pellegata N.S. Hypermethylation, but not LOH, is associated with the low expression of MT1G and CRABP1 in papillary thyroid carcinoma. Int. J. Cancer 104 (2003) 735-744
22. Jiang H., Daniels P.J., and Andrews G.K. Putative zinc-sensing zinc fingers of metal-response element-binding transcription factor-1 stabilize a metal-dependent chromatin complex on the endogenous metallothionein-I promoter. J. Biol. Chem. 278 (2003) 30394-30402
23. Joshi B., Ordonez-Ercan d., Dasgupta P., and Chellappan S. Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors. Oncogene 24 (2005) 2204-2217
24. Kim H.G., Hwang Y.P., and Jeong H.G. Metallothionein-III induces HIF-1α-mediated VEGF expression in brain endothelial cells. Biochem. Biophys. Res. Commun. 369 (2008) 666-671
25. Kimura T., and Itoh N. Function of metallothionein in gene expression and signal transduction: newly found protective role of metallothionein. J. Health Sci. 54 (2008) 251-260
26. LaRochelle O., Labbé S., Harrisson J.-F., Simard C., Tremblay V., St-Gelais G., Govindan M.V., and Séguin C. Nuclear factor-1 and metal transcription factor-1 synergistically activate the mouse metallothionein-1 gene in response to metal ions. J. Biol. Chem. 283 (2008) 8190-8201
27. Laity J.H., and Andrews G.K. Understanding the mechanisms of zinc-sensing by metal-response element binding transcription factor-1 (MTF-1). Arch. Biochem. Biophys. 463 (2007) 201-210
28. Leyshon-Sørland K., Jasani B., and Morgan A.J. The localization of mercury and metallothionein in the cerebellum of rats experimentally exposed to methylmercury. Histochem. J. 26 (1994) 161-169
29. Madsen K.M., Lauritsen M.B., Pedersen C.B., Thorsen P., Plesner A.-M., Andersen P.H., and Mortensen P.B. Thimerosal and occurrence of autism: negative ecological evidence from Danish population-based data. Pediatrics 112 (2003) 604-606
30. Majumder S., Ghoshal K., Li Z., Bo Y., and Jacob S.T. Silencing of metallothionein-I gene in mouse lymphosarcoma cells by methylation. Oncogene 18 (1999) 6287-6295
31. Miles A.T., Hawksworth G.M., Beattie J.H., and Rodilla V. Induction, regulation, degradation, and biological significance of mammlian metallothioneins. Biochem. Mol. Biol. 35 (2000) 35-70
32. Minami T., Oda K., Gima N., and Yamazaki H. Effects of lipopolysaccharide and chelator on mercury content in the cerebrum of thimerosal-administered mice. Environ. Toxicol. Pharmacol. 24 (2007) 316-320
33. Minami, T., Miyata, E., Sakamoto, Y., Yamazaki, H., Ichida, S., in press. Induction of metallothionein in mouse cerebellum and cerebrum with low-dose thimerosal injection. Cell Biol. Toxicol., doi:10.1007/s10565-009-9124-z, published online 09 April 2009.
34. Moffatt P., and Denizeau F. Metallothionein in physiological and physiopathological processes. Drug Metab. Rev. 29 (1997) 261-307
35. Murphy B.J., Kimura T., Sato B.G., Shi Y., and Andrews G.K. Metallothionein induction by hypoxia involves cooperative interactions between metal-responsive transcription factor-1 and hypoxia-inducible transcription factor-1α. Mol. Cancer Res. 6 (2008) 483-490
36. Mutter J., Naumann J., Schneider R., Walach H., and Haley B. Mercury and autism: accelerating evidence?. Neuroendocrinol. Lett. 26 (2005) 439-446
37. Nakajima K., and Suzuki K. Immunochemical detection of metallothonein in brain. Neurochem. Int. 27 (1995) 73-87
38. Nishimura N., Nishimura H., Ghaffar A., and Tohyama C. Localization of metallothionein in the brain of rat and mouse. J. Histochem. Cytochem. 40 (1992) 309-315
39. Ogra Y., Suzuki K., Gong P., Otsuka F., and Koizumi S. Negative regulatory role of Sp1 in metal responsive element-mediated transcriptional activation. J. Biol. Chem. 276 (2001) 16534-16539
40. Penkowa M., and Hidalgo J. Metallothionein I + II expression and their role in experimental autoimmune encephalomyelitis. Glia 32 (2000) 247-263
41. Penkowa M., Tio L., Giralt M., Quintana A., Molinero A., Atrian S., Vašák, and Hidalgo J. Specificity and divergence in the neurobiologic effects of different metallothioneins after brain injury. J. Neurosci. Res. 83 (2006) 974-984
42. Pichichero M., Cernichiari E., Lopreiato J., and Treanor J. Mercury concentrations and metabolism in infant receiving vaccines containing thiomersal: a descriptive study. Lancet 360 (2002) 1737-1741
43. Stajich G.V., Lopez G.P., Harry S.W., and Sexson W.R. Iatrogenic exposure to mercury after hepatitis B vaccination in preterm infants. J. Pediatr. 136 (2000) 679-681
44. Suzuki J.S., Nishimura N., Zhang B., Nakatsuru Y., Kobayashi S., Satoh M., and Tohyama C. Metallothionein deficiency enhances skin carcinogenesis induced by 7 12-dimethylbenz[a]anthracene and 12-O-tetradecanoylphorbol-13-acetate in metallothionein-null mice. Carcinogenesis 24 (2003) 1123-1132
45. Vanguri P. Interferon-γ-inducible genesin primary glial cells of the central nervous system: comparisons of astrocytes with microglia and Lewis with Brown Norway rats. J. Neuroimmunol. 56 (1995) 35-43
46. Waalkes M., Liu J., Kasprzak K.S., and Diwan B.A. Hypersusceptibility to cisplatin carcinogenicity in metallothionein-I/II double knnockout mice: production of hepatocellular carcinoma at clinically relevant doses. Int. J. Cancer 119 (2006) 28-32
47. Waalkes M.P. Quantitation of metallothionein. In: Thomas J.A. (Ed). Endrine Methods (1996), Academic Press Inc. 371-391
48. Westin G., and Schaffner W. A zinc-responsive factor interacts with a metal-regulated enhancer element (MRE) of the mouse metallothionein-I gene. EMBO J. 7 (1988) 3763-3770
49. 0-exposed rat brain. Arch. Toxicol. 77 (2003) 12-16
50. Yasutake A., Sawada M., Shimada A., and Satoh M. Mercury accumulation and its distribution to metallothionein in mouse brain after sub-chronic pulse exposure to mercury vapor. Arch. Toxicol. 78 (2004) 489-495
51. Young J.K., Garvey J.S., and Huang P.C. Glial immunoreactivity for metallothionein in the rat brain. Glia 4 (1991) 602-610
52. Young H.A., Geier D.A., and Geier M.R. Thimerosal exposure in infants and neurodevelopmental disorders: an assessment of computerized medical records in the Vaccine Safety Datalink. J. Neurol. Sci. 271 (2008) 110-118
53. Yu W.H., Lukiw W.J., Bergeron C., Niznik H.B., and Fraser P.E. Metallothionein III is reduced in Alzheimer's disease. Brain Res. 894 (2001) 37-45